Abstract: A pharmaceutical composition containing a mixed polymeric micelle and a drug enclosed in the micelle, in which the mixed polymeric micelle, 1 to 1000 nm in size, includes an amphiphilic block copolymer and a lipopolymer. Also disclosed are preparation of the pharmaceutical composition and use thereof for treating cancer.

Abstract: A method of forming a copolymer includes reacting with to form a salt. x parts by mole of the salt with y parts by mole of are reacted to form the copolymer having a chemical structure as wherein m=4-10, n=4-6, and x:y=1:9 to 4:6. The copolymer may have a relative viscosity of 1.5 to 4.0.

Abstract: A method of forming a copolymer is provided, which includes (i) mixing a diamine and a diester to form a mixture, and heating the mixture to form a diamine compound, wherein the diamine compound has a chemical structure of (ii) mixing the diamine compound and a diacid to form a diamine-diacid salt, wherein the diamine-diacid salt has a chemical structure of and (iii) heating the diamine-diacid salt to polymerize the diamine-diacid salt for forming a copolymer, wherein the copolymer has a repeating unit with a chemical structure of wherein n=2-12, R is and m=2-12.

Abstract: A method and system of obstructed area determination for sleep apnea syndrome are disclosed. The method comprising obtaining a snoring signal from an individual; obtaining a spectrogram of the snoring signal based on short-time Fourier Transform; obtaining a snoring signal feature based on a harmonic wave of the spectrogram; and obtaining a collapse index by comparing the snoring signal feature against a snoring signal feature-collapse index correlation database. The present invention enables the diagnosis of sleep apnea syndrome and determination the obstructed area for the sleep apnea syndrome with only the snoring signal of an individual during sleep.

Abstract: The present invention provides a bed set for inhibition of obstructive sleep apnea, which includes: a sound receiving module, is used to receive a respiratory sound signal obtained from a user during a time period; a sound analyzing processor, which is connected with the sound receiving module, is used to obtain a snoring sound characteristic from the spectrum of respiratory sound signal; a database, which has a plurality of snoring image characteristics corresponding to a plurality of basic snoring sound characteristics for different respiratory actions; a control processor, which is connected with the sound analyzing processor and the database, is used to compare the snoring sound characteristic with the basic snoring sound characteristics to select one of the snoring image characteristics in the same waveform, and provides the first angle control order and the second angle control order corresponding to the selecting snoring image characteristic; a first pillow, which is connected to the control processor,

Abstract: A method of forming a copolymer is provided, which includes (i) mixing a diamine and a diester to form a mixture, and heating the mixture to form a diamine compound, wherein the diamine compound has a chemical structure of (ii) mixing the diamine compound and a diacid to form a diamine-diacid salt, wherein the diamine-diacid salt has a chemical structure of and (iii) heating the diamine-diacid salt to polymerize the diamine-diacid salt for forming a copolymer, wherein the copolymer has a repeating unit with a chemical structure of wherein n=2-12, R is and m=2-12.

Abstract: The present invention provides a bed set for inhibition of obstructive sleep apnea, which includes: a sound receiving module, is used to receive a respiratory sound signal obtained from a user during a time period; a sound analyzing processor, which is connected with the sound receiving module, is used to obtain a snoring sound characteristic from the spectrum of respiratory sound signal; a database, which has a plurality of snoring image characteristics corresponding to a plurality of basic snoring sound characteristics for different respiratory actions; a control processor, which is connected with the sound analyzing processor and the database, is used to compare the snoring sound characteristic with the basic snoring sound characteristics to select one of the snoring image characteristics in the same waveform, and provides the first angle control order and the second angle control order corresponding to the selecting snoring image characteristic; a first pillow, which is connected to the control processor,

Abstract: The present invention provides a nasal suction device, including a collection chamber, a resilient bulb, and a one-way valve. The collection chamber includes a main body, a cover, and an inner space, the cover being detachably connected to the main body in substantially airtight relation, to define the inner space. The resilient bulb is detachably connected to the main body in substantially airtight relation. The cover includes a first tube extending into the inner space, and the secretion passing by the first tube can be suctioned into the collection chamber. The main body includes a second tube, an opening of which adjacent to the resilient bulb is configured with the one-way valve.

Abstract: A method and system of obstructed area determination for sleep apnea syndrome are disclosed. The method comprising obtaining a snoring signal from an individual; obtaining a spectrogram of the snoring signal based on short-time Fourier Transform; obtaining a snoring signal feature based on a harmonic wave of the spectrogram; and obtaining a collapse index by comparing the snoring signal feature against a snoring signal feature-collapse index correlation database. The present invention enables the diagnosis of sleep apnea syndrome and determination the obstructed area for the sleep apnea syndrome with only the snoring signal of an individual during sleep.

Abstract: A copolymer, and a method for preparing a monomer used to form the copolymer are provided. The copolymer is a reaction product of a first monomer and a second monomer. In particular, the first monomer has a structure represented by Formula (I), and the second monomer has a structure represented by Formula (II), Formula (III), or Formula (IV) wherein Y is —NH2, or —CO2H; m is a positive integer from 2 to 10; X is independently —NH2, or —OH; A is CH2n, n is a positive integer from 2 to 10; and, l is a positive integer from 1 to 5.

Abstract: A copolymer, and a method for preparing a monomer used to form the copolymer are provided. The copolymer is a reaction product of a first monomer and a second monomer. In particular, the first monomer has a structure represented by Formula (I), and the second monomer has a structure represented by Formula (II), Formula (III), or Formula (IV) wherein Y is —NH2, or —CO2H; m is a positive integer from 2 to 10; X is independently —NH2, or —OH; A is ?CH2?n, n is a positive integer from 2 to 10; and, l is a positive integer from 1 to 5.

Abstract: A superabsorbent polymer network formed of two monomers and two crosslinkers. The monomers and the crosslinkers are described herein. Further, a method for preparing this superabsorbent polymer network is disclosed. Also disclosed is a method of determining a ratio between two monomeric moieties in a superabsorbent polymer network formed of two monomers.

Abstract: In one embodiment of the disclosure, a composite raw material and a method for forming the same are provided. The method includes sulfonating a polycyclic aromatic compound to form a polycyclic aromatic carbon sulfonate (PCAS); and mixing the polycyclic aromatic carbon sulfonate and a polyacrylonitrile (PAN) to form a composite raw material. In another embodiment of the disclosure, a carbon fiber containing the composite raw material described above and a method for forming the same are provided.

Abstract: In one embodiment of the disclosure, a copolymer and method for manufacturing the same are provided. The copolymer is copolymerized from a composition including: (a) a first hydrophilic monomer, including itaconamic acid, itaconamic salt, or combinations thereof; and (b) a second hydrophilic monomer, including acrylic acid, acrylic salt, acrylamide, or combinations thereof.

Abstract: A precursor raw material for the PAN-based carbon fibers represented by Formula (I) is provided. In Formula (I), R is methyl, ethyl or propyl, x+z=0.5-20.0 mol %, z?0.5 mol %, y=99.5-80.0 mol % and x+y+z=100 mol %. The invention also provides a PAN-based oxidized fiber and a PAN-based carbon fiber prepared by the precursor raw material for the PAN-based carbon fibers.

Abstract: In one embodiment of the disclosure, a copolymer and method for manufacturing the same are provided. The copolymer is copolymerized from a composition including: (a) a first hydrophilic monomer, including itaconamic acid, itaconamic salt, or combinations thereof; and (b) a second hydrophilic monomer, including acrylic acid, acrylic salt, acrylamide, or combinations thereof.

Abstract: In one embodiment of the disclosure, a composite raw material and a method for forming the same are provided. The method includes sulfonating a polycyclic aromatic compound to form a polycyclic aromatic carbon sulfonate (PCAS); and mixing the polycyclic aromatic carbon sulfonate and a polyacrylonitrile (PAN) to form a composite raw material. In another embodiment of the disclosure, a carbon fiber containing the composite raw material described above and a method for forming the same are provided.

Abstract: A plasticizing agent and a composition for fabricating a polyacrylonitrile-based fiber precursor and a fabrication method of a polyacrylonitrile-based carbon fiber are provided. The plasticizing agent includes a copolymer represented by formula (I) or a derivative of formula (I): wherein R is methyl or ethyl, z?0.5 mol %, and y=99.5-85.0 mol %. The plasticizing agent has an intrinsic viscosity of between 0.20-0.40 dL/g. The composition for fabricating the polyacrylonitrile-based fiber precursor includes the plasticizing agent and a polyacrylonitrile-based copolymer having an intrinsic viscosity of between 0.41-0.75 dL/g.

Abstract: An oral fixation device and an oral fixing method using the same are provided. The oral fixation device includes a U-shaped brace and an arch board. The arch board is connected to an inner wall of the U-shaped brace, wherein the central part of the arch board is thicker than the connecting part, and the maximum thickness of the arch board is larger than 2 mm.

Abstract: A method of preparing an aliphatic copolyester by mixing a first compound defined by the equation: and a catalyst, and adding a second compound defined by and a lactide, wherein the second compound and the lactide have a total weight less than the first compound, wherein a is 10-230, b, d and e have a ratio of 10-35:10-35:80-30, c is 1-4, and f is 1-10. The method further adds the second compound and the lactide, wherein the second compound and the lactide have a total weight less than the first compound, the second compound and the lactide in the prior mixing step. The method further adds the second compound and the lactide, wherein the second compound and the lactide have a total weight less than the first compound, the second compound and the lactide in of the prior mixing steps.